Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Apply
KYSA-6
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step